The Lysosomal Storage Disease Treatment Market is expanding due to increased diagnosis rates and innovations in enzyme ...

A novel technology that utilizes light of different wavelengths to control cellular functions by inducing reversible assembly and disassembly of molecules has been developed. This breakthrough could ...

TIANJIN, Nov. 13 (Xinhua) -- A new study led by Chinese scientists has identified a key mechanism behind age-related decline in fertility and demonstrated a potential treatment. The research, ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Abstract Assembly-disassembly dynamics driven by fuel-driven out-of-equilibrium processes play a key role in biological function. Here, we present a ...

The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular ...

Q32025 net revenue of $26.1 million, driven by MIPLYFFA® net revenue of $22.4 millionCompany to host conference call and ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue.

Learn how the study of cell death in ferroptosis can lead to groundbreaking treatments for cancer and neurodegenerative conditions.